Patient Preference and Adherence

Shared Decision-Making in the Management of Urolithiasis

Urolithiasis affects approximately 10% of the global population, with recurrence rates exceeding 50% within five years despite effective medical and surgical interventions. While technological advances have improved stone treatment, long-term success depends heavily on patient adherence to preventive strategies, including dietary modifications, fluid intake and pharmacological regimens. Adherence, however, remains suboptimal and little is known about how patient preferences, values and beliefs influence treatment choices and health behaviours across the care continuum. This Article Collection aims to explore the intersection of urolithiasis management with patient-centred outcomes, including treatment acceptance, lifestyle adherence and satisfaction with shared decision-making. We invite research that moves beyond clinical efficacy to understand what matters most to patients living with recurrent stone disease.